EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+21.94%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.2B
AUM Growth
+$128M
(+12%)
Cap. Flow
-$24.9M
Cap. Flow
% of AUM
-2.07%
Top 10 Holdings %
Top 10 Hldgs %
56.76%
Holding
362
New
28
Increased
88
Reduced
207
Closed
28
Top Buys
| 1 |
Tencent Music
TME
|
$41.7M |
| 2 |
Yum China
YUMC
|
$10.6M |
| 3 |
STAAR Surgical
STAA
|
$8.25M |
| 4 |
Sea Limited
SE
|
$7.13M |
| 5 |
Legend Biotech
LEGN
|
$5.83M |
Top Sells
| 1 |
NIO
NIO
|
$44.7M |
| 2 |
KE Holdings
BEKE
|
$22M |
| 3 |
Kanzhun
BZ
|
$10.1M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$10.1M |
| 5 |
Li Auto
LI
|
$8.53M |
Sector Composition
| 1 | Consumer Discretionary | 36.91% |
| 2 | Technology | 25.51% |
| 3 | Communication Services | 14.94% |
| 4 | Healthcare | 9.44% |
| 5 | Real Estate | 3.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Day One Biopharmaceuticals
DAWN
$773M
| $232K | 0.02% |
+10,764
| New | +$232K |
|
277
Humana
HUM
$37B
| $230K | 0.02% |
450
-73
| -14% | -$37.3K |
|
|
CDMO
278
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $230K | 0.02% |
16,728
+4,749
| +40% | +$65.3K |
|
279
Deere & Co
DE
$128B
| $229K | 0.02% |
+535
| New | +$229K |
|
280
Anavex Life Sciences
AVXL
$807M
| $226K | 0.02% |
24,362
+5,547
| +29% | +$51.5K |
|
281
Fate Therapeutics
FATE
$116M
| $226K | 0.02% |
22,356
+5,404
| +32% | +$54.6K |
|
282
Goldman Sachs
GS
$223B
| $226K | 0.02% |
+657
| New | +$226K |
|
283
Futu Holdings
FUTU
$26.1B
| $225K | 0.02% |
+5,533
| New | +$225K |
|
284
Lockheed Martin
LMT
$108B
| $221K | 0.02% |
+454
| New | +$221K |
|
|
AGEN
285
Agenus
AGEN
$138M
| $220K | 0.02% |
4,673
-212
| -4% | -$9.98K |
|
286
Morgan Stanley
MS
$236B
| $219K | 0.02% |
2,575
-194
| -7% | -$16.5K |
|
287
CrowdStrike
CRWD
$105B
| $218K | 0.02% |
2,074
-64
| -3% | -$6.73K |
|
288
FibroGen
FGEN
$48.9M
| $218K | 0.02% |
544
-82
| -13% | -$32.9K |
|
|
DCPH
289
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $217K | 0.02% |
13,239
-648
| -5% | -$10.6K |
|
290
S&P Global
SPGI
$164B
| $216K | 0.02% |
645
-42
| -6% | -$14.1K |
|
291
SiriusXM
SIRI
$8.1B
| $216K | 0.02% |
3,695
-66
| -2% | -$3.86K |
|
292
Kura Oncology
KURA
$713M
| $213K | 0.02% |
17,173
-2,207
| -11% | -$27.4K |
|
293
Inovio Pharmaceuticals
INO
$148M
| $212K | 0.02% |
11,307
+667
| +6% | +$12.5K |
|
294
McKesson
MCK
$85.5B
| $211K | 0.02% |
563
-82
| -13% | -$30.7K |
|
295
Arcus Biosciences
RCUS
$1.3B
| $211K | 0.02% |
10,214
-5,506
| -35% | -$114K |
|
296
Immunovant
IMVT
$2.99B
| $209K | 0.02% |
+11,799
| New | +$209K |
|
297
Recursion Pharmaceuticals
RXRX
$2.01B
| $209K | 0.02% |
27,111
+15,252
| +129% | +$118K |
|
298
Hewlett Packard
HPE
$31B
| $208K | 0.02% |
13,052
| – | – |
|
299
HCA Healthcare
HCA
$98.5B
| $207K | 0.02% |
+862
| New | +$207K |
|
300
Blackrock
BLK
$170B
| $206K | 0.02% |
+290
| New | +$206K |
|